corp
L1
SonderMind
Sphere us
The metrics
- Posture med
- expanding 5 src →
- Capital · available med
- ~$183-242M cumulative raised across 5 disclosed rounds (Convertible Note $535K 2017, Seed $2.5M 2018, Series A $3M 2019, Series B $27M 2020, Series C $150M Jul-2021); GetLatka sums the … 6 src →
- Capital · operating low
- no official revenue disclosed. Third-party estimator outputs disagree by ~8x: $20M (Zippia), $59.9M (RocketReach), $159M (Compworth, 2026), $10-100M range (IncFact) — none are … 6 src →
- Capital · deployed med
- capital deployed into nationwide network buildout (all 50 states therapy Apr-2025, nationwide psychiatry Nov-2025) and three tuck-in acquisitions (Qntfy ML platform Oct-2021, Total Brain … 5 src →
- Capital · in med
- VC equity rounds only (General Catalyst led Series B; Series C investor syndicate not individually confirmed in sources reached) plus payer-contract/insurance-reimbursement revenue as the … 2 src →
- Capital · out low
- operating spend across a ~50-state clinician network (~12,500 licensed providers) and R&D (AI-assisted matching/practice tools, the Jul-2026 guardrails release); no disclosed multi-year … 2 src →
- Optionality med
- constrained — VC-backed private company (General Catalyst and other undisclosed Series C investors), board oversight, no public listing. Jan-2024 layoffs (~17% of staff) and no fresh primary … 4 src →
- Gravity low
- ~$0.1-0.15B/yr (estimate, low confidence) — reasoned in patients-in-care / payer-contract-revenue terms per the wave recipe, not gross provider/user counts. SonderMind is an in-network … 6 src →
This week — what changed
- The FDA's TEMPO pilot had already filled its behavioral-health slot on 08-24 — Limbic's clinician-supervised AI-voice CBT service "Unpacked" and SonderMind's adjunctive anxiety/depression app — ten days before two of this map's threads still said it had "no participant yet." Both can now reach Medicare's 34 million beneficiaries without prior FDA marketing authorization in exchange for real-world outcomes data, and SonderMind is already a named ACCESS-model applicant. ✏️ Both stale lines (ACCESS Model, AI Therapy Evidence) now carry the correction in place; SonderMind was a watched entity on one of them the whole time. (FDA TEMPO participants, MedTech Dive, STAT News)
Projects & threads
·
ACCESS Model
capital flow
— open · last seen 2026-09-03
· 5 entries
Full item history for SonderMind →
Vocabulary